Novotech has been awarded ‘Australian Exporter of The Year’ the 2017 Indian Australia Business Community (IABCA) Awards. 

India is a key market for Novotech, with the company first establishing its office in Bangalore in 2008. 

“By 2030, India will be one of the top 5 emerging middle class markets in the world. Increasing levels of disposable income and health awareness in India makes it an important market for future clinical trial engagement. Historically, India has had one of the lowest clinical trial penetration rates in Asia and its clinical trials industry has undergone substantial regulatory change over the past three years with the country now positioned as an important international clinical trial destination. Novotech looks forward to continuing to be part of India’s growing clinical trial industry,” said Novotech CEO Dr John Moller. 

For more information about the IABCA Awards, visit  


For more information about the untapped clinical trial benefits available in India, download a free copy of the Frost & Sullivan white papers, ‘Asia: Preferred Destination for Clinical Trials’ or feel free to contact us
About Novotech - 
Headquartered in Sydney, Novotech is internationally recognised as the leading regional full-service contract research organisation (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech’s strong Asia Pacific presence included running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners. 
For RFP enquiries: Please fill out the form available at
Corporate enquiries: Please contact Marketing & Communications Manager Justine Lamond on +61 2 8569 1458 or

Other relevant content